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Maria Prins,b,g Oliver G. Pybus,a and Janke Schinkeld
Department of Zoology, University of Oxford, Oxford, United Kingdoma; Cluster of Infectious Diseases, Public Health Service, Amsterdam, The Netherlandsb; Department
of Medical Microbiology and Infection Control, VUmc University Medical Center, Amsterdam, The Netherlandsc; Department of Medical Microbiology, Academic Medical
Center/University of Amsterdam, Amsterdam, the Netherlandsd; Department of Gastroenterology and Hepatology, Academic Medical Centre/University of Amsterdam,
Amsterdam, The Netherlandse; Department of Internal Medicine, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlandsf; and Department of Internal Medicine,
Academic Medical Centre/University of Amsterdam, CINIMA, Amsterdam, The Netherlandsg
Evolutionary analysis of hepatitis C virus (HCV) genome sequences has provided insights into the epidemic history and trans-
mission of this widespread human pathogen. Here we report an exceptionally diverse set of 178 HCV genotype 2 (HCV-2) iso-
lates from 189 patients in Amsterdam, comprising 8 distinct HCV subtypes and 10 previously not recognized, unclassified lin-
eages. By combining study subjects’ demographic information with phylogeographic andmolecular clock analyses, we
demonstrate for the first time that the trans-Atlantic slave trade and colonial history were the driving forces behind the global
dissemination of HCV-2. We detect multiple HCV-2 movements from present-day Ghana/Benin to the Caribbean during the
peak years of the slave trade (1700 to 1850) and extensive transfer of HCV-2 among the Netherlands and its former colonies In-
donesia and Surinam over the last 150 years. The latter coincides with the bidirectional migration of Javanese workers between
Indonesia and Surinam and subsequent immigration to the Netherlands. In addition, our study sheds light on contemporary
trends in HCV transmission within the Netherlands. We observe multiple lineages of the epidemic subtypes 2a, 2b, and 2c (to-
gether 67% of HCV-2 infections in Amsterdam), which cluster according to their suspected routes of transmission, specifically,
injecting drug use (IDU) and contaminated blood/blood products. Understanding the epidemiological processes that generated
the global pattern of HCV diversity seen today is critical for exposing associations between populations, risk factors, and specific
HCV subtypes andmight help HCV screening and prevention campaigns to minimize the future burden of HCV-related liver
disease.
Infection with hepatitis C virus (HCV) affects an estimated 180million people globally. It is a leading cause of chronic hepatitis,
cirrhosis, and hepatocellular carcinoma and a primary indication
for liver transplantation in developed countries (33). HCV is pri-
marily a blood-borne infection and in developing countries un-
safe medical practices, including injections and transfusions, still
account for an estimated 2 million new HCV infections annually
(34). In developed countries, increased transfusion safety and im-
proved health care conditions have left injecting drug use (IDU) as
the predominant mode of transmission (25). Comprehensive
harm reduction programs including needle exchange programs,
methadone provision, and social medical care have successfully
reduced the number of new IDU-associated HCV infections in
several developed countries, particularly in the Netherlands (45).
Despite of the introduction of increasingly effective drug treat-
ments, the morbidity and mortality attributed to HCV will con-
tinue to be significant over the next 2 decades due to the existing
pool of chronic HCV infections (7).
The genetic diversity of HCV’s single-stranded positive-sense
genome is used to classify the virus into 6 major genotypes and a
provisional genotype 7 (denoted 1 to 7), further subdivided into
numerous subtypes (denoted alphabetically a, b, c, etc.) (36).
HCV genetic diversity varies geographically as a result of differ-
ences in rates and routes of transmission. Epidemic subtypes, ex-
emplified by subtypes 1a, 1b, 2a, 2b, 2c, and 3a are characterized by
high prevalence, low genetic diversity, and a global distribution
following their rapid spread during the 20th century via effective
modes of transmission such as contaminated blood products,
transfusion, IDU, and invasive medical procedures (35). In con-
trast, endemic subtypes exhibit high local genetic diversity due to
low transmission rates and their centuries-long persistence in hu-
man populations in geographically restricted areas, typically in
sub-SaharanAfrica and Southeast Asia (35). Based on present-day
HCV genetic diversity, previous studies have reconstructed the
evolutionary history of both endemic and epidemic HCV lineages
and have successfully linked the time scale of HCV evolution to
epidemiological data on risk factors, transmission routes, and
prevalence (6, 10, 18, 20, 29, 46).
HCVgenotype 2 (HCV-2) accounts for10%of chronicHCV
infections in theNetherlands (43), but unlikeHCVgenotypes 1, 3,
4, and 5 (6, 31, 46), itsmolecular epidemiology in Europe is poorly
understood. HCV-2 exhibits high genetic diversity inWest Africa,
where it has thought to have endemically persisted and spread for
at least 500 years (20). In addition, isolated pockets of endemic
HCV-2 transmission have been found in geographic regions out-
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side Africa, including the Caribbean (21, 39), Indonesia (41), and
Vietnam (26). These lineages fall within the greater African diver-
sity, but the extent of their divergence suggests dissemination
from Africa before the rise of global travel and modern medicine
(20). During the 20th century, transmission via contaminated
blood, blood products, invasive procedures, and IDU eventually
resulted in the global dispersal of HCV-2, particularly subtypes 2a
and 2b, which cause the vast majority of HCV-2 infections in
developed countries (9, 11, 44). Interestingly, two recent studies
from France revealed a wide variety of HCV-2 subtypes, including
among the native French population (5, 40).
Here we report the first study of the diversity and molecular
epidemiology of HCV-2 in the Netherlands. Using phylogeo-
graphic and molecular clock approaches, we investigate the his-
tory and global dissemination of HCV-2. Our results indicate that
the contemporary distribution of HCV-2 in the Netherlands is a
result of both current transmission trends and historical events
inextricably bound up with Dutch colonial history. Further, our
findings help to interpret the complex patterns ofHCV-2 diversity
observed elsewhere and directly address the previously proposed
hypothesis that the trans-Atlantic slave trade was instrumental to
the introduction of HCV to the Americas (20). Increased under-
standing of past and present HCV transmission events helps to
better define risk factors and improve the detection of undiag-
nosed infected individuals, thereby preventing or ameliorating fu-
ture HCV-related liver disease (2).
MATERIALS AND METHODS
Study population. The study population included all patients diagnosed
with a HCV-2 infection at the Academic Medical Center (AMC) or the
AmsterdamPublicHealth Service (APHS) from2000 through 2009. AMC
participants included patients who attended the hepatology outpatient
clinics of either the AMC or a large inner city hospital for which HCV
genotyping is performed at the AMC. APHS participants were members
of surveys performed to monitor the general population or groups at risk
for sexually transmitted and blood-borne infections; all signed an in-
formed consent. For eachHCV-2-infected participant, data on age, coun-
try of birth, HIV status, and plausible route of infection were collected, if
available. HCV risk groups were classified into four ranked categories: (i)
injecting drug users (IDUs), (ii) recipients of blood or blood products,
(iii) migrants from non-Western countries (countries in Asia, Africa, and
Latin America), (iv) other exposures (including, e.g., nosocomial, perina-
tal, and sexual/household exposure) (Table 1), and (v) unknown. Indi-
viduals belonging to more than one risk group were classified into the
highest-ranked risk category.
RNA isolation, reverse transcription, PCR, and sequencing. RNA
isolation, reverse transcription, PCR, and sequencing were performed as
described previously (6). Transcribed cDNAwas used as the input for two
separate HCV PCR assays targeting the NS5B region, resulting in the
amplification of two overlapping NS5B fragments. Fragment 1 (340 nu-
cleotides [nt]; nt 8001 to 8340) and fragment 2 (421 nt; nt 8288 to 8709)
were concatenated, resulting in an NS5B sequence of a total length of 709
nt. Sera and RNA isolates were stored at80°C.
Phylogenetic analyses. Ancestral relationships among HCV isolates
were inferred by reconstructing phylogenetic trees of our NS5B se-
quences, together with confirmed and provisionally assigned HCV-2
reference sequences from the HCV sequence database (15). Maximum
likelihood (ML) phylogenies were estimated using the Hasegawa-Kin-
isho-Yano nucleotide substitution model plus a gamma-distribution
model of among-site rate heterogeneity (HKY-) (13) as implemented in
GARLI v0.95 (50). ML phylogenies were midpoint rooted, and the statis-
tical robustness of phylogenetic branches was tested byML bootstrapping
with 100 replicates. In addition, ML phylogenies were estimated for each
of the three epidemic subtypes (2a, 2b, and 2c) separately, to identifyHCV
transmission networks linked to specific HCV transmission routes/risk
groups. These subtype-specific phylogenies included the fragment 1 (341
nt) NS5B sequences of our study participants along with all available
homologous reference sequences in the HCV database (15). Reference
sequences were retained if they represented nonrecombinant isolates
from natural human infections. The entire alignment was further tested
for recombination using PhiTest (4), as implemented in SplitsTree
v.4.12.3 (14). The test provided strong statistical evidence for a lack of
recombination (P 0.99).
Molecular clock and phylogeographic analyses. The long-term evo-
lutionary history and global dissemination of HCV-2 were assessed by
reconstructing a relaxed molecular clock phylogeny using the Bayesian
Markov chainMonte Carlo (MCMC) approach and the HKY- substitu-
tion model implemented in BEAST v1.4.6 (8). The relaxed molecular
clock model was preferred over a strict clock after a formal model test
resulting in an ln Bayes factor of 96.5 (38). Reference sequences with
known sampling locations and dates were chosen such that the full genetic
diversity of HCV-2 was evenly represented; only four representatives of
each epidemic subtype (2a, 2b, and 2c) were retained. To maximize sam-
ple size, we used all reference sequences that were homologous to any part
of the concatenated NS5B Amsterdam sequences and which spanned at
least 290 nt of the concatenated alignment. Based on previous estimates,
the inferred rate of nucleotide evolution for the NS5B sequences was
0.0005 substitutions per site per year (23, 30). Multiple MCMC chains
TABLE 1 Epidemiological characteristics of the study population
Characteristic
No. of patients
(n 189)
% of
patients
Sex
Female 65 34
Male 124 66
Country or region of birth
Western 111 59
The Netherlands 88 46
Western Europe, USA, Australia 20 11
Eastern Europe 3 2
Non-Western 71 37
Surinam 45 24
Morocco 10 5
Indonesia 6 3
Other 10 5
Unknown 7 4
Transmission risk factor
IDU 76 40
Blood transfusiona 33 18
Non-Western country of birth 48 25
Otherb 14 7
Unknown 18 10
HIV status
Positive 12 6
Negative 110 58
Unknown 67 35
a Sixteen of 33 participants who reported to have received blood or blood products
received transfusion in a non-Western country: 11 in Surinam, 2 in Morocco, 1 in
Algeria, 1 in the Dominican Republic, and 1 in the United Arab Emirates.
b Other reported routes of transmission included sexual transmission (6 participants),
nosocomial transmission (3), unhygienic tattooing (2), perinatal transmission (2), and
needle-stick injury (1).
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were calculated and output files were combined using LogCombiner 1.5.4
with an appropriate burn-in removed. MCMC convergence and effective
sample sizes were checked using Tracer v1.5 (http://beast.bio.ed.ac.uk). A
summary phylogeny (maximum clade credibility [MCC] tree) was gener-
ated using TreeAnnotator v1.5.4 (http://beast.bio.ed.ac.uk). The geo-
graphic states of ancestral lineages were reconstructed using a parsimony
approach (37), and the MCC phylogeny was annotated using Figtree
(http://tree.bio.ed.ac.uk). The parsimony analysis suggested that there
were insufficient lineage migration events to justify the use of parametric
phylogeographicmethods (16). The following criteria were used to define
geographic clusters: (i) phylogeographic (lineage movement) event at the
root of the clade, (ii) clade support of80, (iii) at least two-thirds of the
sequences forming the cluster being from one location (excluding se-
quences that form a subcluster resulting from a subsequent phylogeo-
graphic event).
Dating of lineage migration events. Viral lineage migration events
were estimated using the two nodes of the phylogenetic branch on which
the change in location state occurs: the descendant (X) and ancestral (Y)
nodes. The estimated dates of nodes X and Y (together with their 95%
highest posterior density [HPD] credible regions) were obtained from the
MCC tree anddefine a timewindowduringwhich lineagemovement took
place. The most conservative (i.e., widest) estimate of the lineage migra-
tion date range is given by the more recent 95%HPD limit of node X and
the older 95%HPD of node Y. All subtrees defined by node X were highly
supported; however, many of the subtrees defined by node Y were not.
When the support of node Y was50%, the preceding node was used to
define the older time limit of the migration interval. The older 95%HPD
of this node was then used as the most ancient plausible date of lineage
movement.
Testing for association between geography and phylogeny. To test
for an association between phylogenetic clustering and geographic loca-
tion, BaTS (28) was used to perform a test of phylogeographic structure.
The robustness of phylogeographic clustering was assessed by comparing
the calculated posterior distribution of the parsimony score (PS) and as-
sociation index (AI) statistics of tip-trait association (37, 49) with their
null distributions under the hypothesis of no phylogenetic structure.
BaTS explicitly includes phylogenetic uncertainty, and therefore any sig-
nificant result obtained is robust to the sequence length used (28).
Trans-Atlantic slave trade historic data. The number of individuals
transported across the Atlantic Ocean during the entire period of trans-
Atlantic slave trade was downloaded from the Trans-Atlantic Slave Trade
Database (47). The adjusted number of captives, as well as the adjusted
number of captives disembarked at the Dutch Guianas and in total in the
NewWorld, were downloaded in quarter-century periods.
Nucleotide sequence accession numbers and reference sequences
used todetermine viral genotype.All 178HCVNS5B sequences obtained
in this study have been submitted to GenBank. This includes 167 concat-
enated NS5B sequences (709 nt) with accession numbers JF722454
through JF722620, plus 11 partial sequences (NS5B fragment 1 or 2 only;
see above) with accession numbers DQ238634, DQ238635, DQ238659,
DQ238673, and JQ746501 through JQ746507. The subtype of each se-
quence was determined in a preliminary analysis using confirmed and
provisionally assigned HCV-2 reference sequences from the HCV se-
quence database (15, 36). These included D009944 (2a), D10988 (2b),
D50409 (2c), D49761 (2e), D49777 (2f), DQ155565 (2i), D86530 (2j),
AB031663 (2k), andD86529 (2q), spanning the complete 709 nucleotides
of our concatenated NS5B fragment; and L29634 (2d), L48494 (2l),
AY434117 (2m), L44602 (2n), L38373 (2o), L44601 (2p), and EF116040
(2r), for the first 341 nucleotides (fragment 1) only.
RESULTS
Study population. In total, 189 HCV-2 infected individuals were
identified: 129 were diagnosed at the AMC and 60 at the APHS.
Study subjects had a median age of 47 years (interquartile range:
41 to 57 years), 66% were male, and only 59% were born in Eu-
rope, North America, or Australia (Table 1). The predominant
underlying risk factors for acquiring HCV-2 infection were IDU
(40%), being born in a non-Western country (mostly Surinam;
25%), and a history of blood transfusion (17%). Interestingly,
16/33 (48%) of the HCV-2 infected individuals with a history of
blood transfusion were transfused in a non-Western country.
Only 122/189 (65%) of the study subjects were tested for HIV. Of
the 12HIV-positive individuals, 10were current or previous IDUs
and 2 were men who have sex with men (MSM).
RNA isolation, reverse transcription, PCR, and sequencing.
Amplification and sequencing of the concatenated 709-bp NS5B
fragment were successful for 167/189 (88%) patients. For an ad-
ditional 11 patients, NS5B sequences were obtained for either
NS5B fragment 1 only (n 2) or NS5B fragment 2 only (n 9).
Hence, HCV genotyping and phylogenetic analysis could be per-
formed for 178/189 (94%) of patients based on the availability of
(partial) NS5B sequence data. For the remaining 11 patients, no
NS5B sequence data were obtained (Table 2). Of these, 7 patients
had no serum or plasma available, and for 4 patients, all born in
Surinam, amplification of both NS5B fragment 1 and NS5B frag-
ment 2 failed.
Phylogenetic analyses. A phylogenetic tree was constructed
for our study sequences plus established reference sequences from
the HCV sequence database (Fig. 1). Amsterdam sequences fall
into 13 distinct monophyletic clades, 1 homologous pair and 5
singleton sequences, representing 8 known HCV-2 subtypes and
10 phylogenetically distinct and yet unclassified HCV-2 lineages
(Table 2). All monophyletic clades were supported by high boot-
strap scores (70%; blue circles).
The majority of Amsterdam sequences (61%) belonged to the
three epidemic subtypes 2a, 2b, and 2c. Individuals infected with
these subtypes were mostly born in the Netherlands or other
Western countries and reported a history of either IDU or blood
transfusion (Table 2). We estimated separate phylogenies of sub-
types 2a, 2b, and 2c that included all isolates fromAmsterdamplus
all available reference sequences. Figure 2 depicts the ML phylog-
eny ofHCV-2a. In addition to numerous isolates fromAsia and an
HCV-2a cluster from countries of the former Soviet Union, this
phylogeny features two clades dominated by isolates of European
origin and suggests two separate transmission networks for
HCV-2a in the Netherlands. The large “IDU cluster” (n  45)
exhibits low genetic diversity, reflecting the recent and rapid
transmission of this HCV-2a lineage among IDUs in Europe (29).
The smaller clade (n 5) exclusively consists of individuals from
Amsterdam who received a blood transfusion in the Netherlands.
Interestingly, only 7 of 35HCV-2a isolates obtained fromAmster-
dam were not part of the two European clusters. None of these
seven participants were born in western Europe; the high genetic
similarity of their infections with HCV-2a strains from the indi-
viduals’ country of birth suggests that all seven had acquiredHCV
beforemoving to theNetherlands. Figure 2 contains only 34 of the
35 HCV-2a infected study participants because amplification of
NS5B fragment 1 failed in one patient. Additional phylogenetic
analysis based on NS5B fragment 2 suggests that this patient was
part of the European IDU cluster (data not shown). The phylog-
enies of HCV-2b and HCV-2c showed similar patterns, but epi-
demiologically meaningful groupings of sequences from Dutch
individuals were not so clear-cut (data not shown). We were able
to confirm one heterosexual (HCV-2c) and one homosexual
(HCV-2b) transmission event.
Colonial History and HCV-2 Diversity in Amsterdam
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In addition to the epidemic subtypes (2a, 2b, and 2c), phylo-
genetic analysis revealed 15 “nonepidemic” HCV-2 subtypes and
lineages, which infected 33% (62/189) of our study population
(Table 2). Only 23/62 (37%) of nonepidemic isolates could be
classified as recognized HCV-2 subtypes (specifically, 2e, 2f, 2i, 2j,
and 2r). The remaining 39 isolates grouped into 10 distinct un-
classifiedHCV-2 lineages, each affecting 1 to 12 individuals. Non-
epidemic isolates predominantly represent Amsterdam residents
of Surinamese ancestry plus isolates from individuals of Indone-
sian, African, or Caribbean ancestry (Table 2). Only 5 of the 62
individuals infected with a nonepidemic strain were born in the
Netherlands; 2 of these had Surinamese ethnicity and were most
likely infected perinatally, 1 had a needle-stick injury (source un-
known), 1 acquired HCV sexually (ethnicity of partner un-
known), and for 1 no information on transmission risk was avail-
able. All blood transfusions associated with HCV-2 infections
other than HCV-2a, 2b, or 2c were performed in non-Western
countries.
Molecular clock and phylogeographic analyses. To investi-
gate the longer-term ancestry ofHCV genotype 2 isolates from the
Netherlands, we reconstructed a relaxed molecular clock tree
from an alignment enriched for endemic HCV-2 strains. This
phylogeny spans a period of nearly 600 years (Fig. 3). Branches are
colored according to each individual’s country of birth, and iso-
lates from Amsterdam are noted by black circles. We identified
several major clades associated with endemic persistence in West
Africa: (i) the lower 2 clades (green) mainly consist of isolates
from Guinea-Bissau and include an early lineage migration to
Madagascar (pink); (ii) a clade in the middle (red) that consists of
sequences sampled in Cameroon; and (iii) the large upper clade
(blue) represents HCV strains from the Ghana/Benin area and
contains numerous strongly supported geographic clusters of iso-
lates sampled from various parts of the world, each satisfying our
cluster definition criteria. Five of these subclusters are dominated
by strains from Surinam-born individuals (clades G, H, I, K, and
L), two clades are predominantly associated with people from In-
donesia (E and F) and others with individuals fromMorocco (C),
Vietnam (D), Martinique (N), and Hispaniola (M). The two
aforementioned Surinamese clades (H and I) group into a single
and older migrant clade (J), statistical support for which is weaker
(posterior probability 0.66).
Figure 3 also provides evidence for secondarymigration events
after HCV has been exported fromAfrica.We identified a subtype
2f Indonesian clade (F) that originates from a Surinamese lineage,
as well as three Surinamese isolates that group inside a larger sub-
type 2e Indonesian clade (E). Further, a pair of subtype 2i Viet-
namese isolates (orange) cluster amid a clade of predominantly
Moroccan strains (C). All these secondary migration events are
well supported, although the direction of the second Indonesian/
Surinamesemovement is not certain. There are three possibilities:
(i) movement from Surinam to Indonesia, (ii) movement from
Indonesia to Surinam, and (iii) movement from Indonesia to Su-
rinam and then back to Indonesia.
Dating of lineagemigration events. From themolecular clock
TABLE 2 HCV-2 genetic diversity, country of birth, and transmission risk factor
HCV subtype
No. of patients
(n 189)
% of
patients
Transmission risk Patient origin
IDU Transfusion Endemic Other
No
info Westernb
Country of birth of
majority of patients
Epidemic subtypes
Total 116 61 73 16 4 10 13 100 Westernb
2a 35 18 19 6 4 0 7 27 Netherlands
2b 72 38 53 6 3 6 6 64 Netherlands
2c 9 5 1 4 0 4 0 9 Netherlands/Italy
Recognized endemic
subtypes
Total 23 12 0 7c 14 0 2 0 Non-Westernb
2e 6 3 0 0 5 0 1 0 Surinam/Indonesia
2f 5 3 0 3 2 0 0 0 Surinam
2i 9 5 0 3 6 0 0 0 Morocco
2j 1 1 0 0 0 0 1 0 Venezuela
2r 2 1 0 1 1 0 0 0 Dominican Republic
Unclassified endemic
lineages
Total 39 21 0 7c 26 4 2 5 Non-Westernb
2(I) 12 6 0 0 8 3 1 4 Surinam
2(II) 11 6 0 4 5 1 1 1 Surinam
2(III) 5 3 0 0 5 0 0 0 Surinam
2(IV) 4 2 0 2 2 0 0 0 Surinam
2(V to X)a 7 4 0 1 6 0 0 0 Surinam
No PCR fragment
Total 11 6 3 3 4 0 1 6 Westernb
a Six distinct unclassified endemic lineages each comprising one or two isolates.
b Western origin means all countries in Europe plus the United States, Canada, Australia, and New Zealand.
c All transfusions which resulted in chronic infections with endemic HCV-2 strains were performed in non-Western countries.
Markov et al.
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FIG 1 Maximum likelihood phylogeny including the 167 sequences originating from our study spanning both fragments 1 and 2. Taxon labels are colored by
individual’s risk factor: red, IDU; blue, blood transfusion/nosocomial; green, sexual/MSM; brown, birth in a non-Western country and also include the
individual’s country of birth using International Organization for Standardisation (ISO) codes. Blue dots indicate well-supported clades (bootstrap value 70).
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FIG2 Maximum likelihood phylogeny of subtype 2a sequences fromour study and all available homologous reference sequences in theHCV sequence database.
Dots next to taxon names indicate sequences originating from our study. Taxon labels are color coded by risk factor: red, IDU; blue, blood transfusion. Tip labels
denote the country of birth for sequences originating from our study and the country of isolation for sequences obtained from theHCV sequence database using
International Organization for Standardization (ISO) codes.
Markov et al.
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FIG 3 Molecular clock phylogeny of endemic HCV genotype 2 strains. Black dots next to phylogeny tips indicate sequences resulting from our study. Tree
branches are colored according to inferred lineage locations: green, West Africa (Senegal, Gambia, Guinea Bissau, and Guinea); blue, Benin-Ghana area (Benin,
Burkina Faso, and Ghana); red, (Cameroon, Central African Republic); pink, Madagascar; brown, Caribbean; orange, Asia; light blue, North Africa; black,
Western countries. Orange dots on nodes indicate well-supported clades (posterior probability 80); red dots on nodes indicate clades with excellent support
(posterior probability 90). The capital letters with arrows label the root nodes of the major migrant clades.
Colonial History and HCV-2 Diversity in Amsterdam
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tree, we obtained estimated dates of phylogenetic nodes that de-
fine conservative lower and upper limits for the timing of lineage
migration events. The lower box of Fig. 4a shows only those HCV
lineages that moved across the Atlantic Ocean; the upper box
shows HCV-2 lineages that moved to other destinations. These
estimated migration dates are displayed above a graph that shows
the numbers of individuals transported from West Africa during
the transatlantic slave trade (Fig. 4b). Both the total number of
transported slaves (gray line) and the number transported to
Dutch Guianas (a historical colonial territory that includes pres-
ent-day Surinam; black line) are shown. All transatlantic move-
ments are estimated to have occurred within the period of trans-
Atlantic slave trade (1650 to 1900). The majority of the dating
intervals end before 1850. The substantial uncertainty of the upper
bound for the date ofmovement of cladeM toHispaniola is due to
(i) the long internal branch that precedes this clade and (ii) the low
statistical support for the pre-migration node ancestral to cladeM
(Fig. 3).
Migration of HCV-2 lineages fromWest Africa to Central Af-
rica (A) and Madagascar (B) is dated to the 17th century. HCV
lineage migration to Morocco is dated to between the early 17th
and early 19th centuries, reflecting a considerable uncertainty in
the older time limit (for the same reasons as those applying to
clade M). Movement of HCV-2 to Vietnam most likely occurred
between the second halves of the 18th and 19th centuries, with a
lower 95%HPD limit that stretches into the late 17th century. The
two lineage migrations to Indonesia happened at distinctly differ-
ent times. The earlier migration most likely occurred sometime
between the mid-18th and the late 19th centuries, while the more
recent migration, which represents the movement of HCV-2f to
Indonesia from Surinam, is dated to the first few decades of the
20th century.
Testing for association between geography and phylogeny.
Table 3 shows the results of the statistical test for significant phy-
logeographic structure in the phylogeny. The association index
(AI) is significant for all geographical locations, except for Marti-
nique, while the parsimony score (PS) is statistically significant for
all locations. This is a strong evidence for geographical grouping
in the phylogeny, and the conclusion is robust in terms of phylo-
genetic estimation uncertainty.
DISCUSSION
Our analysis of HCV-2 from the Amsterdam area uncovered sub-
stantial viral genetic diversity, including 8 knownHCV-2 subtypes
and 10 previously unclassified subtype-like lineages, and revealed
a complex phylogenetic pattern associated with geography and
risk groups. As discussed below, these associations are most likely
driven by a combination of social, demographic, and economic
factors over both recent and historical timescales. The phyloge-
netic distribution of the previously unclassified lineages suggests
that they represent separate subtypes; however, our data did not
satisfy the complete criteria for assigning new subtypes (36).More
sampling and (complete) genome sequences will be required be-
fore these lineages can be definitively classified. To obtain a broad
sample ofHCV infections, we included patients from an academic
hospital, an inner-city hospital, and the public health service, of
which the latter specifically deals with groups at risk for sexually
transmitted and blood-borne infections. Although this study in-
cludes all patients diagnosed with HCV-2 at these three large cen-
ters in Amsterdam during a 10-year time period, selection bias
cannot entirely be excluded.
The majority of Amsterdam isolates belonged to the epidemic
subtypes 2a, 2b, and 2c commonly found inwestern Europe (9, 11,
43). During the 20th century, the growth of parenteral routes of
transmission resulted in the worldwide exponential growth of
HCV, including HCV subtypes 2a, 2b, and 2c (30). Although the
phylogenies of these subtypes revealed similar epidemiological
profiles, the existence of “epidemic” transmission networks for
HCV-2 is best illustrated by the HCV-2a phylogeny (Fig. 2). The
FIG 4 Estimated time periods of HCV genotype 2 global lineage migrations
and the numbers of individuals transported as part of the trans-Atlantic slave
trade over time. (a) Molecular clock-based intervals for lineage migration
dates and their credible intervals: lower box, trans-Atlantic migration events;
upper box, migration events to other areas. Gray circles in the middle of the
intervals indicate our best estimate of time of migration. In some estimates a
vertical bar is shown, representing an ancestral node with weak support. In
these cases, the left end of the interval represents a conservative estimate of the
upper date ofmigration (seeMaterials andMethods).Whiskers represent 95%
highest posterior density (HPD) credible regions of the most conservative
estimates on both sides. Color coding as in Fig. 3. Capital letters in brackets
next to arrival destinations correspond to the clade labels in Fig. 3. CAR,
Central African Republic. (b) Number of individuals transported as part of the
trans-Atlantic slave trade over time: black line, numbers of individuals disem-
barked in Dutch Guianas; gray line, total numbers of individuals disembarked
in theNewWorld (in quarter-century periods). Brownmarks indicate the best
estimates for times of movement of the trans-Atlantic infection lineages.
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tree contains two risk-group-specific HCV-2a lineages in Amster-
dam, one associated with contaminated blood transfusion and
one with IDU. The IDU cluster is larger than the transfusion clus-
ter, genetically less diverse, and also comprises strains from Ger-
many, France, and Spain interspersed among the Dutch samples.
This is typical for a recent introduction of a single virus that rap-
idly spread to IDU communities in neighboring countries via a
joint transmission network. Similar observations have been made
for HCV subtype 4d, which entered southern European IDU pop-
ulations as early as 1954 and spread efficiently northwards there-
after (6, 42). In contrast, transfusion clusters remain country spe-
cific. We also identified a second transfusion-related cluster
containing isolates mostly from former Soviet republics. The ter-
ritorial clustering of transfusion-related isolates is perhaps unsur-
prising given that blood banks are organized at the national level.
However, we note that these risk group clades do not receive
strong statistical support, most likely due to insufficient phyloge-
netic signal, and therefore we suggest they should be interpreted
with caution.
In addition to the epidemic subtypes, we observed 5 known
endemic HCV subtypes and 10 distinct unclassified HCV-2 lin-
eages each affecting 1 to 12 individuals, together accounting for
one-third of our isolates. Endemic HCV-2 lineages have been
found at varying frequencies in other Western countries (10% of
HCV-2 infections in Canada to 67% in southeast France [24, 40]).
In contrast to the French studies, the vast majority of Amsterdam
endemic isolates were from individuals born outside the Nether-
lands, in Africa, Asia, or Latin America, particularly Surinam and
Indonesia. The high frequency of endemic strains from the last
two countries is unsurprising given the long history of Dutch co-
lonial rule there. Nevertheless, HCV-2 reveals a remarkably wide-
spread geographic distribution, with a pronounced geographical
structure. Statistical tests demonstrated that isolates from each
individual location significantly group together on the phylogeny.
While incomplete sampling may contribute to this pattern, it also
reflects the global nature of human movement during the 500
years prior to 1900. And while migration of HCV lineages within
continental Africa could have resulted from land travel or the
gradual diffusion of viruses through local interaction, the only
plausible route by which HCV lineages could have moved among
continents before the 20th century is via the emergence and rise of
global marine navigation for exploration and trade.
Our results demonstrate the existence ofmultiple HCV-2 “mi-
grant clusters,” which represent lineages thatmoved at some point
in the past from West Africa (where HCV-2 originated [20]) to
other areas. Among others, these lineages include HCV-2e and 2f
to Indonesia; HCV-2i to Morocco, France, Vietnam, and Quebec
(24, 26, 40); HCV-2j to Venezuela (39); HCV-2k to Martinique
and France (21); HCV-2m to Vietnam (26); HCV-2r to Haiti and
the Dominican Republic (24); and numerous nonclassified di-
verse HCV-2 lineages to Surinam. Strikingly, multiple separate
migrations of HCV occurred from Africa to various countries in
the Caribbean. Even a relatively small territory such as Surinam
received multiple independent viral introductions, each drawn
from the broader pool of HCV-2 diversity in West Africa. The
likely low prevalence of endemic HCV in Africa and its low infec-
tivity prior to the age of modern medicine suggest that such pat-
tern was likely generated by a process that involved themovement
of substantial numbers of Africans.
Crucially, in this study, we used a combined phylogeographic
and molecular clock approach to directly test the previously pro-
posed hypothesis (20) that HCV was introduced to the Americas
by the trans-Atlantic slave trade. If this hypothesis is correct, then
the timing of viral introductions should coincide with the period
of slave transportation as estimated from historical records. The
transatlantic slave trade started gradually at the beginning of 16th
century and ended in the latter half of the 19th century, during
which it was responsible for the forcedmovement of an estimated
10.7 million people from Africa to the Americas (47). We used
evolutionary analysis to estimate the date of movement of each
migrant lineage with appropriate confidence limits: the midpoint
of these limits represents our best estimate of the date of viral
introduction.Most of the estimated timewindows for viralmigra-
tions fell within the 150 years between 1700 and 1850. This coin-
TABLE 3 Phylogeographic structure: association indices and parsimony scoresa
Statistic Geographic cluster Observed mean (95% CI) Null mean (95% CI) Significance
Association index Surinam 0.98 (0.53–1.46) 6.54 (5.33–7.8) 0.01
Hispaniola 0.004 (0.002–0.01) 1.25 (0.79 1.65) 0.01
Martinique 1.39 (1.041.7) 1.81 (1.3–2.21) 0.08
Indonesia 0.59 (0.35–0.97) 3.30 (2.51–3.94) 0.01
Vietnam 0.3 (0.13–0.47) 1.49 (1.05–1.91) 0.01
Morocco 0.85 (0.52–1.16) 2.42 (1.84–2.9) 0.01
Benin-Ghana 1.82 (1.26–2.39) 5.95 (4.94–6.79) 0.01
Guinea-Gambia 1.04 (0.6–1.53) 4.83 (3.97–5.71) 0.01
Cameroon/CAR 0.54 (0.37–0.74) 2.76 (2–3.43) 0.01
Parsimony score Surinam 11.37 (10–13) 34.67 (32.36–36.58) 0.01
Hispaniola 1 (1–1) 5.95 (5.52–6.0) 0.01
Martinique 6.76 (6–7) 8.91 (8.14–9) 0.01
Indonesia 4.96 (4–6) 16.49 (15.5–17) 0.01
Vietnam 3 (3–3) 6.95 (6.66–7) 0.01
Morocco 7.06 (6–8) 11.83 (11.01–12) 0.01
Benin-Ghana 20.69 (18–23) 30.51 (29.03–31.81) 0.01
Guinea-Gambia 11.32 (10–12) 24.18 (22.94–24.97) 0.01
Cameroon/CAR 7 (7–7) 13.65 (12.86–14) 0.01
a CI, confidence interval; CAR, Central African Republic.
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cides with the historical period during which slave shipments
reached their peak. Although trans-Atlantic slave trade continued
for nearly 4 centuries, more than 80% (approximately 8.8 million
people) of Africans ever transportedweremoved across the Atlan-
tic during these 150 years (47).
Phylogeographic analysis provides a second line of evidence
supporting the trans-Atlantic slave trade hypothesis. All the
HCV-2 trans-Atlantic “migrant clusters” (including those from
Surinam) originated from the Benin-Ghana region of Africa (blue
in Fig. 3) while none originate from Senegambia (green in Fig. 3).
Present-day Ghana and Benin featured 30 European trading posts
along their coast from the 15th to 19th centuries, compared to
only 5 posts among the four countries of Senegambia (48). Ap-
proximately 2.8 million slaves were moved to the New World
from the Gold Coast and Bight of Benin (present-day Ghana, Be-
nin, and Burkina Faso) between the 16th and 19th centuries,
whereas600,000 slaves were transported from Senegambia dur-
ing the same period. The former’s relatively short span of coast
was the embarkation point of more than a quarter of all people
transported (47).
The trans-Atlantic slave trade has been proposed as the driving
force of intercontinental expansion of other viruses. A recent phy-
logenetic study suggests thatWest African hepatitis B virus (HBV)
lineages were introduced to Haiti during the peak years of slave
movement (1). Similarly, recent studies of human T-cell leukemia
virus type 1 (HTLV-1), which sometimes combine human and
viral evidence, have indicated that Surinamese, Guyanan, Brazil-
ian, Argentinian, and Peruvian HTLV-1 lineages grouped among
West African lineages (3, 12, 32).
Although the trans-Atlantic slave trade provides a plausible
explanation for themovement ofHCV-2 to the Americas, it leaves
the long-term presence of endemic HCV-2 in Asia unexplained.
European nations likely played a role in the global dissemination
of HCV, additionally through trade and other forms of human
migration among their colonies. An example is subtype 2e, which
links an endemic HCV-2 lineage from the Benin-Ghana area to
Indonesia. Dutch companies establishedmultiple trading ports in
this part of Africa and traded intensively with the largest Dutch
colonial territory—Indonesia. Records also suggest the significant
movement of African slaves from West Africa to the Dutch Cape
colony and Asia by Dutch traders (27). Our results also highlight
secondary lineage movements among colonial territories sharing
the samemetropole. Subtypes 2e and 2f suggest viralmovement in
both directions between the former Dutch colonies of Surinam
and Indonesia. Although the timing and direction of subtype 2e
migration is uncertain, we provide evidence that HCV-2f moved
from Surinam to Indonesia during the early 20th century. These
more recent movements are consistent with the bidirectional mi-
gration of initially 2,600 Chinese migrant workers mainly from
Java (Indonesia) between 1853 and 1874, and later 33,000 Java-
nese contract laborers from Indonesia to Surinam during 1890 to
1940, a direct consequence of the abolition of slavery in the latter
by the Dutch government in 1862 (19, 22). About a quarter of
these laborers returned to Indonesia at the end of their 5-year
contract in the period between 1897 and 1956. People of Javanese
descent still comprise 15 to 20% of the present-day Surinamese
population (17).
By combining demographic, historical, and viral genetic data,
we have reconstructed the transmission history of HCV-2, which
explains its worldwide distribution as well as the present-day pat-
tern of diversity observed in Amsterdam. It appears that the colo-
nial activities of European countries played a decisive role in the
dissemination of HCV genotype 2, predominantly to the Ameri-
cas, but also to former colonial territories in Asia. Interestingly,
HCV subtype 2i (cluster C in Fig. 3) falls within the Benin-Ghana
region and solely contains isolates from francophone regions, in-
cluding Morocco, France, Quebec, and Vietnam (former French
Indochina). Although indicative of a role for the colonial activities
of France in the dispersal ofHCV-2i, our sample of “Dutch origin”
is not sufficiently representative to address this hypothesis. The
Benin-Ghana region of Africa, both a major embarkation area for
vessels carrying slaves to the Americas and an important trading
post along European-Asian trading routes, emerges as an impor-
tant historical hub of global HCV-2 distribution. Since the global
epidemic HCV subtypes 1a and 1b were estimated to originated
from theUnited States (18), we hypothesize here that trans-Atlan-
tic slave trade was also responsible for themovement to the Amer-
icas of these genotype 1 endemic African lineages.Molecular clock
dating of transatlantic movements of HCV from West Africa
strongly supports our historical slave trade hypothesis. In addition
to information on the global nature of human movement before
1900, our phylogenetic analysis of epidemic subtypes 2a, 2b, and
2c, together 67% of HCV-2 infections in our study, exposed both
national and international transmission networks responsible for
the emergence of HCV-2 in most Western countries during the
20th century, specifically injecting drug use and contaminated
blood/blood products. Undiagnosed chronically HCV-infected
individuals might benefit from an increased understanding of the
epidemiological processes that generated the global pattern of
HCV diversity seen today. Better understanding of the associa-
tions between risk factors, populations, and HCV subtypes might
help target HCV prevention and screening campaigns and de-
crease the future burden of HCV-related liver disease.
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